Consistent with its role in natural antibody recognition, IGHV1-2 is frequently used by neonatal cord blood IgM+ lymphocytes [72] and in MZ B cell lymphomas [73, 74], which are thought to derive from chronic pathogen-mediated selection [75]. This evidence concerns the gene CD40LG and B-cell non-Hodgkin lymphoma.